Padmavathi Sundar Oncocyte Corp (OCX) insider trading activity

OCX Quotes by TradingView

Padmavathi Sundar is Chief Commercial Officer of Oncocyte Corp. Currently has a direct ownership of 4,177 shares of OCX, which is worth approximately $9,147. The most recent transaction as insider was on Dec 11, 2020, when has been sold 4,177 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.18K
0% 3M change
0% 12M change
Total Value Held $9,147

Padmavathi Sundar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2020
BUY
Grant, award, or other acquisition
-
4,177 Added 50.0%
4,177 Common Stock
PS

Padmavathi Sundar

Chief Commercial Officer
Irvine, CA

Track Institutional and Insider Activities on OCX

Follow Oncocyte Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

News

Receive news related to Oncocyte Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCX